342612-83-3 Usage
Description
(S)-2-Benzyloxycarbonylamino-4,4-difluoro-butyric acid methyl ester, a methyl ester derivative of (S)-2-benzyloxycarbonylamino-4,4-difluoro-butyric acid, is a white to off-white crystalline solid with a molecular formula of C14H16F2N2O4 and a molar mass of 314.28 g/mol. It has a melting point in the range of 80-83°C and is commonly used in the pharmaceutical industry as an intermediate for the synthesis of various pharmaceutical compounds.
Uses
Used in Pharmaceutical Industry:
(S)-2-Benzyloxycarbonylamino-4,4-difluoro-butyric acid methyl ester is used as a chemical intermediate for the synthesis of various pharmaceutical compounds. Its unique structure and reactivity make it a valuable component in the development of new drugs and therapies.
Used in Drug Synthesis:
In the field of drug synthesis, (S)-2-Benzyloxycarbonylamino-4,4-difluoro-butyric acid methyl ester is used as a key building block for creating novel pharmaceuticals. Its incorporation into drug molecules can enhance their efficacy, selectivity, and pharmacokinetic properties, leading to improved treatment options for various medical conditions.
Used in Research and Development:
(S)-2-Benzyloxycarbonylamino-4,4-difluoro-butyric acid methyl ester is also utilized in research and development laboratories for studying its chemical properties and potential applications in drug discovery. Its reactivity and structural features make it an interesting candidate for exploring new synthetic routes and developing innovative pharmaceutical agents.
Check Digit Verification of cas no
The CAS Registry Mumber 342612-83-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,4,2,6,1 and 2 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 342612-83:
(8*3)+(7*4)+(6*2)+(5*6)+(4*1)+(3*2)+(2*8)+(1*3)=123
123 % 10 = 3
So 342612-83-3 is a valid CAS Registry Number.
342612-83-3Relevant articles and documents
SELECTIVE KINASE INHIBITORS
-
, (2013/06/06)
Provided are pyrimidine compounds for inhibiting of Syk kinase, intermediates used in making such compounds, methods for their preparation, pharmaceutical compositions thereof, methods for inhibition Syk kinase activity, and methods for treating conditions mediated at least in part by Syk kinase activity.
